BML (BMLKF) ROCE %: 5.36% (As of Mar. 2026)

What is BML ROCE %?

BML BMLKF 69 ROCE % is 5.36% as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 69/100 and a GF Value™ of $26.78. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. BML's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.36%.

BML (OTCPK:BMLKF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

BML ROCE % Related Terms

BML ROCE % Historical Data

* Premium members only.

The historical data trend for BML's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML ROCE % Chart

BML Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

ROCE %

Get a 7-Day Free Trial

42.88

17.50

6.73

6.97

8.15

BML Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															4.38	8.38	10.79	10.14	5.36

69GF Score

BML Inc BMLKF

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

BML ROCE % Calculation

BML's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2026 )		(A: Mar. 2025 )		(A: Mar. 2026 )
	=	76.291	/	( ( (1226.861 - 252.218)	+	(1154.801 - 257.665) )	/ 2 )
	=	76.291	/	( (974.643	+	897.136)	/ 2 )
	=	76.291	/	935.8895
	=	8.15 %

BML's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	47.44	/	( ( (1134.336 - 262.226)	+	(1154.801 - 257.665) )	/ 2 )
	=	47.44	/	( ( 872.11	+	897.136 )	/ 2 )
	=	47.44	/	884.623
	=	5.36 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 5.36% mean?

BML (BMLKF) has a ROCE % of 5.36% as of Mar. 2026.

Is BML's ROCE % too high?

BML's current ROCE % is 5.36%. Overall, BML has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.

How does BML's ROCE % compare to TMO and DHR?

BML's ROCE % of 5.36% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Diagnostics & Research company?

A good ROCE % depends on the Medical Diagnostics & Research industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. BML's current ROCE % is 5.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is BML stock overvalued right now?

BML (BMLKF) has a current ROCE % of 5.36%. The stock's GF Value™ is $26.78, compared to a current price of $25.21 — trading 5.9% below its estimated fair value. The current ROCE % is 5.36%. BML's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For BML (BMLKF), the current ROCE % is 5.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 5.9% below its estimated GF Value™ of $26.78.

Key valuation signals for BMLKF:

ROCE %: 5.36%
GF Value™: $26.78 vs. price of $25.21 (5.9% below fair value)
GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BML Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSE:4544 TSE:2395 TSE:4671 TSE:3386 TSE:6090 TMO DHR SHSE:603259 XSWX:LONN IDXX A WAT NTRA IQV ILMN MTD DGX LH GH MEDP

Other Exchanges 4694:Japan

Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051

Website http://www.bml.co.jp

BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.

69GF Score

Get the complete analysis for BMLKF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21

Price

$26.78

GF Value

View BMLKF Analysis

See ROCE % data for all stocks →